Health
CHIEF-HF: Heart Failure Symptoms Improved With Canagliflozin in Remote Trial – DocWire News
In a fully remote trial, researchers found that canagliflozin, originally developed to treat type-2 diabetes, appeared to greatly…
In a fully remote trial, researchers found that canagliflozin, originally developed to treat type-2 diabetes, appeared to greatly improve symptoms and quality of life in adults with heart failure, whether or not they also had type 2 diabetes. Findings from…
Continue Reading
-
Business16 hours ago10 ASX shares to buy after the market selloff
-
General20 hours ago‘We are here for you’: PM to bring help to flood zones
-
Business16 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
General18 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening